Enjoy complimentary customisation on priority with our Enterprise License!
The quinidine sulfate market share is expected to increase by USD 427.29 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.7%.
This quinidine sulfate market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers quinidine sulfate market segmentation by disease type (malaria and arrhythmias) and geography (North America, Europe, Asia, and Rest of World (ROW)). The quinidine sulfate market report also offers information on several market vendors, including Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. among others.
Download Report Sample to Unlock the Quinidine Sulfate Market Size for the Forecast Period and Other Important Statistics
The growing incidence of malaria is notably driving the quinidine sulfate market growth, although factors such as the emergence of insecticide-resistant vectors may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the quinidine sulfate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Quinidine Sulfate Market Driver
Key Quinidine Sulfate Market Trend
Key Quinidine Sulfate Market Challenge
This quinidine sulfate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global quinidine sulfate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the quinidine sulfate market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the quinidine sulfate market encompasses successful business strategies deployed by the key vendors. The quinidine sulfate market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The quinidine sulfate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the quinidine sulfate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
37% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the quinidine sulfate market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The increasing funding for the development of anti-malarial medicines will facilitate the quinidine sulfate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 in 2020, which affected a large population in the region, boosted the demand for modification of anti-malarial drugs, including quinidine sulfate. Hence, the COVID-19 pandemic had a positive impact on the growth of the regional market, and it is expected to grow during the forecast period
To gain further insights on the market contribution of various segments Request PDF Sample
The quinidine sulfate market share growth in the malaria segment will be significant during the forecast period. Malaria is a life-threatening disease that is caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. Moreover, quinidine sulfate is used alone or with other medications to treat malaria in countries such as India and China where malaria is common. Thus, the rising prevalence of malaria, increase in malaria awareness programs, and initiatives by governments to control and prevent the prevalence of malaria across the globe are expected to increase the demand for quinidine sulfate during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the quinidine sulfate market size and actionable market insights on post-COVID-19 impact on each segment.
Quinidine Sulfate Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.7% |
Market growth 2022-2026 |
$ 427.29 million |
Market structure |
Concentrated |
YoY growth (%) |
5.11 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Disease Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.